A Multicenter, Open-Label, Dose-Escalation, Investigator-Initiated Trial for 5-Day Repeated Intramuscular Administration of NK-104-NP to Treat Chronic Critical Limb Ischemia

Trial Profile

A Multicenter, Open-Label, Dose-Escalation, Investigator-Initiated Trial for 5-Day Repeated Intramuscular Administration of NK-104-NP to Treat Chronic Critical Limb Ischemia

Completed
Phase of Trial: Phase I/II

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Peripheral ischaemia
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 30 Mar 2017 Status changed from active, no longer recruiting to completed.
    • 01 Sep 2016 Status changed from recruiting to active, no longer recruiting.
    • 08 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top